Skip to main content
Log in

Effects of the putative P-type calcium channel blocker, R,R-(−)-daurisoline on neurotransmitter release

  • Original Articles
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

The alkaloid and medicinal herb constituent, R,R-(−)-daurisoline, was originally reported to be a N-type Ca2+ channel blocker, but newer evidence indicates that it is a blocker of P-type Ca2+ channels. To clarify its specificity with respect to N- and P-channels, we compared its effects on the electrically induced release of endogenous glutamate, 3H-GABA and 3H-noradrenaline, from brain slices with those of ω-agatoxin IVA and ω-conotoxin GVIA. Like ω-agatoxin IVA (but with about 1000-fold lower potency), and unlike ω-conotoxin GVIA, R,R-(−)-daurisoline inhibited the release of 3H-GABA and glutamate, with IC50 values of 8 and 18 μM. However, inhibition particularly of 3H-GABA release was more complete than by ω-agatoxin IVA, indicating interaction with one or more additional voltage-sensitive Ca2+ channels, possibly the Q-type. Its potency to inhibit glutamate release elicited either electrically, by veratrine or by high concentrations of K+ was similar, in contrast to sodium channel blockkes. The effects of R,R-(−)-daurisoline on the release of 3H-noradrenaline, 3H-dopamine and 3H-acetylcholine were in agreement with previous knowledge from experiments with ω-agatoxin IVA suggesting an involvement of P-channels. A weak inhibition of 3H-noradrenaline release at 10 μM, similar to that by ω-agatoxin IVA at 0.03 μM, was occluded by α2-antagonistic properties and could be unmasked in presence of rauwolscine. At 10 μM, it also inhibited electrically evoked 3H-dopamine and 3H-5-hydroxytryptamine release and caused a marked spontaneous release of all three monoamines in a reserpine-like manner. Spontaneous and evoked release of 3H-acetylcholine was inhibited by about 25% at 10 μM.

In radioligand binding studies, R,R-(−)-daurisoline interacted with α1 and α2-adrenoceptors, 5-HT2 and muscarinic cholinergic receptors with IC50 values close to 1 μM, and with μ opiate receptors even with 0.18 μM. Atropine reduced the weak inhibitory effect of R,R-(−)-daurisoline on 3H-acetylcholine release somewhat, suggesting that it was brought about by both P channel blockade and cholinergic agonist activity. The effect on 3H-GABA release was unaffected by naloxone, indicating that the interaction of R,R-(−)-daurisoline with μ opiate receptors is antagonistic.

The pattern of effects on neurotransmitter release observed with R,R-(−)-daurisoline resembles that of ω-agatoxin IVA and supports previous electrophysiological data suggesting that the compound blocks P-type voltage-sensitive Ca2+ channels. However, the more complete blockade of amino acid release by R,R-(−)-daurisoline suggests interaction with additional Ca+ channel subtypes. Although it does also possess other pharmacological properties, we think that the compound is suitable to test whether blockade of glutamate release via voltage-sensitive Ca2+ channels is a viable concept to obtain novel neuroprotective and/or anticonvulsant compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Beaumont K, Chilton WS, Yamamura HI, Enna SJ (1978) Muscimol binding in rat brain: association with synaptic GABA receptors. Brain Res 148:153–162

    Google Scholar 

  • Benoit E, Escande D (1991) Riluzole specifically blocks inactivated Na channels in myelinated nerve fibers. Pflügers Arch 419:603–609

    Google Scholar 

  • Bittiger H, Reymann N, Hall R, Kane P (1988) CGP 27492, a new, potent and selective radioligand for GABA, receptors. (11th ENA meeting, Zürich. Abstract No. 16). Eur J Neurosci 10 [Suppl]:60

    Google Scholar 

  • Bosmann HB, Denney DP, Case KR, DiStefano P, Averitt K (1978) Diazepam receptor: specific binding of [3H]diazepam and [3H]flunitrazepam to rat brain subtractions. FEBS Lett 87:199–202

    Google Scholar 

  • Bradbury AF, Smyth DG, Snell CR, Birdsall NJ, Hulme EC (1976) C-fragment of lipotropin has a high affinity for brain opiate receptors. Nature 260:793–795

    Google Scholar 

  • Burke SP, Adams ME, Taylor CP (1993) Inhibition of endogenous glutamate release from hippocampal tissue by Ca2+ channel toxins. Eur J Pharmacol 238:383–386

    Google Scholar 

  • Bylund DB, Snyder SH (1976) Beta adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol 12:568–580

    Google Scholar 

  • Capogna M, Gähwiler BH, Thompson SM (1993) Mechanism of mu-opioid receptor mediated presynaptic inhibition in the rat hippocampas in vitro. J Physiol (Lond) 470:539–558

    Google Scholar 

  • Closse A, Bittiger H, Langenegger D, Wanner A (1987) Binding studies with [3H]cis-methyldioxolane in different tissues. Naunyn-Schmiedeberg's Arch Pharmacol 335:372–377

    Google Scholar 

  • Dooley DJ, Lupp A, Hertting G (1987) Inhibition of central neurotransmitter release by ω-conotoxin GVIA, a peptide modulator of the N-type voltage-sensitive calcium channel. Naunyn-Schmiedeberg's Arch Pharmacol 336:467–470

    Google Scholar 

  • Dunlap K, Luebke JI, Turner TJ (1995) Exocytotic Ca2+ channels in mammalian central neurons. TINS 18:89–98

    Google Scholar 

  • Gaur S, Newcomb R, Rivnay B, Bell JR, Yamashiro D, Ramachandran J, Miljanich GP (1994) Calcium channel antagonist peptides define several components of transmitter release in the hippocampas. Neuropharmacology 33:1211–1219

    Google Scholar 

  • Greengrass P, Bremner R (1979) Binding characteristics of 3H-prazosin to rat brain α1-adrenergic receptors. Eur J Pharmacol 55:323–326

    Google Scholar 

  • Hua W, Kong R (1989) Total synthesis of R,R-(−)-daurisoline. Chem Abstr 110:193–168g

    Google Scholar 

  • Keith RA, Mangano TJ, Pacheco MA, Salama AI (1989) Characterization of the effects of omega-conotoxin GVIA on the responses of voltage-sensitive calcium channels. J Anton Pharmacol 9: 243–252

    Google Scholar 

  • Kelly RB (1993) Storage and release of neurotransmitters. Cell 72:43–53

    Google Scholar 

  • Lambert NA, Harrison NL, Teyler TJ (1991) Evidence for μ opiate receptors on inhibitory terminals in area CAI of the rat hippocampus. Neurosci Lett 124:101–104

    Google Scholar 

  • Leach MJ, Marden CM, Miller AA (1986) Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 27:490–497

    Google Scholar 

  • Leach MJ, Swan JH, Eisenthal D, Dopson M, Nobbs M (1993) BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage. Stroke 24:1063–1067

    Google Scholar 

  • Leysen JE, Niemegeers CJ, VanNueten JM, Laduron PM (1982) 3H-ketanserin (R 41468) a selective 3H-ligand for serotonin2 eceptor binding sites: Binding properties, brain distribution and functional role. Mol Pharmacol 21:301–314

    Google Scholar 

  • Li SC (1982) Ben Caw Gang Mu. People's health of China pp. 181–182

  • Löscher W (1993) Basic aspects of epilepsy. Curr Opinion Neurol Neurosurg 6:223–232

    Google Scholar 

  • Lu YM, Liu GQ (1990) The effects of (−)-daurisoline on Ca2+ influx in presynaptic nerve terminals. Br J Pharmacol 101:45–48

    Google Scholar 

  • Lu YM, Zhang JT, Zhao FQ, Qin YF (1991) Effects of Ca2+ antagonists on glutamate release and Ca2+ influx in the hippocampus with in vivo intracerebral microdialysis. Br J Pharmacol 104:222–226

    Google Scholar 

  • Lu YM, Lu BF, Zhao FQ, Yan YL, Ho XP (1993) Accumulation of glutamate is regulated by calcium and protein kinase C in rat hippocampal slices exposed to ischemic states. Hippocampus 3:221–228

    Google Scholar 

  • Lu YM, Fröstl W, Dreessen J, Knöpfel T (1994) P-type calcium channels are blocked by the alkaloid daurisoline. NeuroReport 5:1489–1492

    Google Scholar 

  • Martin D, Thompson MA, Nadler JV (1993) The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. Eur J Pharmacol 250:473–476

    Google Scholar 

  • Miller AA, Wheatley P, Sawyer DA, Baxter MG, Roth B (1986) Pharmacological studies on lamotrigine, a novel potential antiepileptic drug. I. Anticonvulsant profile in mice and rats. Epilepsia 27:483–489

    Google Scholar 

  • Mizoule J, Meldrum B, Mazadier M, Croucher M, Ollat C, Uzan A, Legrand J-J, Gueremy C, Le Fur G (1985) 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission. I. Anticonvulsant properties. Neuropharmacology 24:767–773

    Google Scholar 

  • Nelson PL, Herbet A, Bourgoin S, Glowinski J, Hamon M (1978) Characteristics of central 5-HT receptors and their adaptive changes following intracerebra1 5,7-dihydroxytryptamine administration in the rat. Mol Pharmacol 14:983–995

    Google Scholar 

  • Patel J, Marangos PJ, Stivers J, Goodwin FK (1982) Characterization of adenosine receptors in brain using N6 cyclohexyl-(3H)adenosine. Brain Res 237:203–214

    Google Scholar 

  • Pin J-P, Bockaert J (1990) Omega-Conotoxin GVIA and dihydropyridines discriminate two types of Ca2+ channels involved in GABA release from striatal neurons in culture. Eur J Pharmacol 188:81–84

    Google Scholar 

  • Pocock JM, Nicholls DG (1992) A toxin (Aga-GI) from the venom of the spider Agelenopsis aperta inhibits the mammalian presynaptic Ca2+ channel coupled to glutamate exocytosis. Eur J Pharmacol-Mol Pharmacol 226:343–350

    Google Scholar 

  • Pratt J, Rataud J, Bradot F, Roux M, Blanchard J-C, Laduron PM, Stutzmann J-M (1992) Neuroprotective actions of riluzole in rodent models of global and focal ischemia. Neurosci Lett 140:225–230

    Google Scholar 

  • Protti DA, Uchitel OD (1993) Transmitter release and presynaptic Ca2+ currents blocked by the spider toxin ω-AGA-IVA. NeuroReport 5:333–336

    Google Scholar 

  • Randall AD, Wendland B, Schweizer F, Miljanich G, Adams ME, Tsien RW (1993) Five pharmacologically distinct high voltage-activated Ca2+ channels in cerebellar granule cells. (Abstract) Soc Neurosci Abstr 19:607.3

    Google Scholar 

  • Rataud J, Debarnot F, Mary V, Pratt J, Stutzmann J-M (1994) Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodents. Neurosci Lett 172:19–23

    Google Scholar 

  • Sugita S, North RA (1993) Opioid actions on neurons of rat lateral amygdala in vitro. Brain Res 612:151–155

    Google Scholar 

  • Tanaka T, Starke K (1980) Antagonist/agonist-preferring α-adrenoceptors or α12-adrenoceptors? Eur J Pharmacol 63:191–194

    Google Scholar 

  • Thate A, Meyer DK (1989) Effect of ω-conotoxin GVIA on release of 3H-γ-aminobutyric acid from slices of rat neostriatum. Naunyn-Schmiedeberg's Arch Pharmacol 339:359–361

    Google Scholar 

  • Tran VH, Chang RSL, Snyder SH (1978) Histamine H1 receptors identified in mammalian brain membranes with 3H-mepyramine. Proc Natl Acad Sci USA 12:6290–6294

    Google Scholar 

  • Turner TJ, Adams ME, Dunlap K (1992) Calcium channels coupled to glutamate release identified by ω-AGA-IVA. Science 258:310–313

    Google Scholar 

  • Turner TJ, Adams ME, Dunlap K (1993) Multiple Ca2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc Natl Acad Sci USA 90:9518–9522

    Google Scholar 

  • Waldmeier PC, Williams M, Baumann PA, Bischoff S, Sills MA, Neale RF (1988) Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT, receptor subtypes in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 337:609–620

    Google Scholar 

  • Waldmeier PC, Wicki P, Feldtrauer J-J (1993) Release of endogenous glutamate from rat cortical slices in presence of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid. Naunyn-Schmiedeberg's Arch Pharmacol 348:478–485

    Google Scholar 

  • Waldmeier PC, Baumann PA, Wicki P, Feldtrauer JJ, Stierlin Ch, Schmutz M (1995) Similar potency of carbamazepine, oxcarbazepine and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology (in press)

  • Zhang JF, Randall AD, Ellinor PT, Horne WA, Sather WA, Tanabe T, Schwarz TL, Tsien RW (1993) Distinctive pharmacology and kinetics of cloned neuronal Ca2+ channels and their possible counterparts in mammalian CNS neurons. Neuron 11:291–303

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waldmeier, P.C., Wicki, P., Fröstl, W. et al. Effects of the putative P-type calcium channel blocker, R,R-(−)-daurisoline on neurotransmitter release. Naunyn-Schmiedeberg's Arch Pharmacol 352, 670–678 (1995). https://doi.org/10.1007/BF00171327

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00171327

Key words

Navigation